Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more ...

Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly ...

Trump's plan to lower Medicare drug costs by aligning U.S. prices with other countries faces legal and industry challenges.

Experts said Trump’s action could potentially lower the cost of prescription drugs, perhaps by the 30 percent to 80 percent ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

There are expenses that Medicare won't cover in 2025, and it's important to find other ways to cover these costs.

It’s unclear what — if any — impact the Republican president’s executive order will have on millions of Americans who have ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

President Donald Trump signed a sweeping executive order Monday morning that promises to crack down on “unreasonable or ...